Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Testing the Addition of Ipatasertib to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) for Stage III or IV Epithelial Ovarian CancerAdnexal Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, endocrine system disorder, fallopian tube disorder, fallopian tube endometrioid adenocarcinoma, fallopian tube neoplasm, female reproductive system disorder, female reproductive system neoplasm, gonadal disorder, malignant endocrine neoplasm, neoplasm, ovarian cancer, ovarian disorder, ovarian endometrioid adenocarcinomaActive, not recruitingPhase 12026-09-22NCT05276973

2 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
National Cancer Institute (NCI)3015
NRG Oncology93

8 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Augusta University Medical CenterAugustaUnited States117
Cleveland Clinic FoundationClevelandUnited States370
Fox Chase Cancer CenterPhiladelphiaUnited States259
Medical College of WisconsinMilwaukeeUnited States483
UCSF Medical Center-Mission BaySan FranciscoUnited States114
University of Oklahoma Health Sciences CenterOklahoma CityUnited States491
VCU Massey Comprehensive Cancer CenterRichmondUnited States273
Women and Infants HospitalProvidenceUnited States63